Literature DB >> 8374060

Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A).

R Malhotra1, J Haurum, S Thiel, J C Jensenius, R B Sim.   

Abstract

Lung surfactant protein A (SP-A) is the most abundant surfactant-associated protein present in the lung. A receptor for SP-A has been shown to be present on A549 alveolar type II cells and on other cell types, including alveolar macrophage. The SP-A receptor on A549 cells has been identified as the collection receptor, or C1q receptor, which binds several structurally-related ligands. SP-A contains C-type lectin domains, but the role of carbohydrate binding by SP-A in physiological and pathological phenomena is not yet established. In this paper we report the binding of SP-A to pollen from Populus nigra italica (Lombardy Poplar), Poa pratensis (Kentucky blue grass), Secale cerale (cultivated rye) and Ambrosia elatior (short ragweed). Saturable and concentration dependent binding of SP-A to pollen grains was observed. Interaction of SP-A with pollen grains takes place through water-extractable components, in which the major species present, in Lombardy polar pollen, are 57 kD and 7 kD (glyco)proteins. The binding of SP-A to pollen grains and their aqueous extracts was calcium ion dependent and was inhibited by mannose, and is therefore mediated by the lectin domain. Binding of SP-A to pollen grains was found to mediate adhesion of pollen grains to A549 cells. The results suggest that pollen grains or other carbohydrate-bearing particles (e.g. microorganisms) could potentially interact with different cell types via the collection receptor (C1q Receptor) in the presence of SP-A.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8374060     DOI: 10.1007/bf01145960

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  22 in total

Review 1.  Therapeutic use of surfactant components in allergic asthma.

Authors:  Veit J Erpenbeck; Norbert Krug; Jens M Hohlfeld
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

2.  Human lung surfactant protein A exists in several different oligomeric states: oligomer size distribution varies between patient groups.

Authors:  T P Hickling; R Malhotra; R B Sim
Journal:  Mol Med       Date:  1998-04       Impact factor: 6.354

3.  Epigenome-wide effects of vitamin D on asthma bronchial epithelial cells.

Authors:  Nadia Boutaoui; Sandeep Puranik; Rong Zhang; Ting Wang; Daniel H Hui; John Brehm; Erick Forno; Wei Chen; Juan C Celedón
Journal:  Epigenetics       Date:  2019-06-03       Impact factor: 4.528

Review 4.  The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections.

Authors:  SeungHye Han; Rama K Mallampalli
Journal:  Ann Am Thorac Soc       Date:  2015-05

Review 5.  Metal nanomaterials: Immune effects and implications of physicochemical properties on sensitization, elicitation, and exacerbation of allergic disease.

Authors:  Katherine A Roach; Aleksandr B Stefaniak; Jenny R Roberts
Journal:  J Immunotoxicol       Date:  2019-12       Impact factor: 3.000

6.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Allergen particle binding by human primary bronchial epithelial cells is modulated by surfactant protein D.

Authors:  Carsten Schleh; Veit J Erpenbeck; Carla Winkler; Hans D Lauenstein; Matthias Nassimi; Armin Braun; Norbert Krug; Jens M Hohlfeld
Journal:  Respir Res       Date:  2010-06-22

8.  Binding of human collectins (SP-A and MBP) to influenza virus.

Authors:  R Malhotra; J S Haurum; S Thiel; R B Sim
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

9.  Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils.

Authors:  T Madan; U Kishore; A Shah; P Eggleton; P Strong; J Y Wang; S S Aggrawal; P U Sarma; K B Reid
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2.

Authors:  David S Phelps; Todd M Umstead; Patricia Silveyra; Sanmei Hu; Guirong Wang; Joanna Floros
Journal:  J Proteom Genom Res       Date:  2013-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.